| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Cristina Cunha | Q47314450 |
| Agostinho Carvalho | Q47504201 | ||
| Katrien Lagrou | Q50099914 | ||
| Samuel M Gonçalves | Q59670718 | ||
| Cláudio Duarte-Oliveira | Q60364489 | ||
| P2093 | author name string | Johan A Maertens | |
| P2860 | cites work | The microbiome of the lung | Q24602074 |
| Compartmentalized control of skin immunity by resident commensals | Q24603475 | ||
| The skin microbiome | Q24634180 | ||
| A homozygous CARD9 mutation in a family with susceptibility to fungal infections | Q24658090 | ||
| The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus | Q24811208 | ||
| Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation | Q42230664 | ||
| Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation | Q42851594 | ||
| Editorial overview: host-microbe interactions: fungi: heterogeneity in fungal cells, populations, and communities | Q43159103 | ||
| Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections | Q43593080 | ||
| Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study | Q43631437 | ||
| Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4-/- mice | Q44086922 | ||
| Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. | Q45760347 | ||
| Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum | Q46277042 | ||
| Airway Microbiota Determines Innate Cell Inflammatory or Tissue Remodeling Profiles in Lung Transplantation | Q46539385 | ||
| Host-microorganism interactions in lung diseases | Q46810894 | ||
| Sputum microbiota in moderate versus severe patients with COPD. | Q46962967 | ||
| Aspergillosis | Q55951920 | ||
| Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity | Q58855374 | ||
| PTX3-Based Genetic Testing for Risk of Aspergillosis After Lung Transplant: Table 1 | Q60451853 | ||
| Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice | Q82703707 | ||
| Regulation of lung immunity and host defense by the intestinal microbiota | Q26779232 | ||
| Control of pathogens and pathobionts by the gut microbiota | Q27013060 | ||
| Paving the way for predictive diagnostics and personalized treatment of invasive aspergillosis | Q28081259 | ||
| Induction of intestinal Th17 cells by segmented filamentous bacteria | Q28131638 | ||
| Genetic variation in Toll-like receptors and disease susceptibility | Q28267031 | ||
| Duodenal infusion of donor feces for recurrent Clostridium difficile | Q28283517 | ||
| The gut microbiota--masters of host development and physiology | Q28286102 | ||
| Invasive aspergillosis in the intensive care unit | Q28306909 | ||
| Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 | Q28509150 | ||
| IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis | Q28534626 | ||
| Global Analysis of the Fungal Microbiome in Cystic Fibrosis Patients Reveals Loss of Function of the Transcriptional Repressor Nrg1 as a Mechanism of Pathogen Adaptation | Q28551061 | ||
| The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management | Q28730299 | ||
| Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome | Q28829667 | ||
| Modulation of potential respiratory pathogens by pH1N1 viral infection. | Q30423825 | ||
| The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide | Q31144277 | ||
| The interplay between the innate immune system and the microbiota | Q31151778 | ||
| PTX3, a humoral pattern recognition molecule at the interface between microbe and matrix recognition | Q33632044 | ||
| The changing microbial epidemiology in cystic fibrosis | Q33825634 | ||
| Deep dermatophytosis and inherited CARD9 deficiency | Q33855073 | ||
| The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography | Q33901596 | ||
| Reciprocal interactions of the intestinal microbiota and immune system. | Q34033579 | ||
| Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary Aspergillosis infection | Q34182454 | ||
| The role of the microbiome in exacerbations of chronic lung diseases | Q34199591 | ||
| PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients | Q34406338 | ||
| Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts | Q34412019 | ||
| Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation. | Q34518423 | ||
| Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation | Q34533098 | ||
| Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis | Q34536205 | ||
| Human genetics shape the gut microbiome. | Q34630305 | ||
| The emerging world of the fungal microbiome | Q34727901 | ||
| Microbiota regulates immune defense against respiratory tract influenza A virus infection | Q34750186 | ||
| The Y238X stop codon polymorphism in the human β-glucan receptor dectin-1 and susceptibility to invasive aspergillosis | Q34772679 | ||
| Human genetic susceptibility to invasive aspergillosis | Q34945368 | ||
| A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. | Q35001502 | ||
| A risk prediction score for invasive mold disease in patients with hematological malignancies | Q35005712 | ||
| A breath fungal secondary metabolite signature to diagnose invasive aspergillosis | Q35029333 | ||
| Application of a neutral community model to assess structuring of the human lung microbiome | Q35072309 | ||
| Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis | Q35081904 | ||
| The lung mycobiome: an emerging field of the human respiratory microbiome. | Q35082308 | ||
| Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes | Q35131913 | ||
| Lung microbiota promotes tolerance to allergens in neonates via PD-L1. | Q35165937 | ||
| Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals | Q35172371 | ||
| The potential impact of the pulmonary microbiome on immunopathogenesis of Aspergillus-related lung disease | Q35277785 | ||
| Topographical continuity of bacterial populations in the healthy human respiratory tract | Q35528519 | ||
| Functional analysis of cilia and ciliated epithelial ultrastructure in healthy children and young adults | Q35535836 | ||
| The Lung Microbiome: New Principles for Respiratory Bacteriology in Health and Disease | Q35687192 | ||
| The Gut-Lung Axis in Respiratory Disease | Q35848701 | ||
| Microbiota regulate the ability of lung dendritic cells to induce IgA class-switch recombination and generate protective gastrointestinal immune responses | Q35880265 | ||
| Asthma Prevention by Lactobacillus Rhamnosus in a Mouse Model is Associated With CD4(+)CD25(+)Foxp3(+) T Cells | Q35895198 | ||
| Biogeography of a human oral microbiome at the micron scale | Q35904645 | ||
| Enhancement of Microbiota in Healthy Macaques Results in Beneficial Modulation of Mucosal and Systemic Immune Function | Q35908830 | ||
| Metagenomic Sequencing of the Chronic Obstructive Pulmonary Disease Upper Bronchial Tract Microbiome Reveals Functional Changes Associated with Disease Severity | Q35922452 | ||
| Lung microbiome dynamics in COPD exacerbations | Q35936580 | ||
| Does the microbiota regulate immune responses outside the gut? | Q35946273 | ||
| The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications | Q35987288 | ||
| The evolution of cooperation within the gut microbiota. | Q35998247 | ||
| Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity | Q36002388 | ||
| The Colonic Crypt Protects Stem Cells from Microbiota-Derived Metabolites | Q36041507 | ||
| The microbiome and innate immunity | Q36069070 | ||
| Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis | Q36204582 | ||
| Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study. | Q36344062 | ||
| Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease | Q36390314 | ||
| Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells. | Q36614277 | ||
| Commensal bacteria calibrate the activation threshold of innate antiviral immunity | Q36921389 | ||
| Pulmonary Th17 Antifungal Immunity Is Regulated by the Gut Microbiome | Q37018586 | ||
| Comparison of the respiratory microbiome in healthy nonsmokers and smokers | Q37073006 | ||
| Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. | Q37229478 | ||
| CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands | Q37380370 | ||
| Role of antibiotics and fungal microbiota in driving pulmonary allergic responses | Q37521749 | ||
| Epidemiology of invasive mycoses in North America | Q37678397 | ||
| Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study. | Q37717451 | ||
| Beneficial effects of probiotics in upper respiratory tract infections and their mechanical actions to antagonize pathogens | Q38025737 | ||
| Microbiota abnormalities in inflammatory airway diseases - Potential for therapy | Q38130813 | ||
| Innate lymphoid cells and asthma | Q38200228 | ||
| Host genetics of invasive Aspergillus and Candida infections | Q38268925 | ||
| Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂. | Q38311200 | ||
| Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation | Q38578579 | ||
| GPR43 - A Prototypic Metabolite Sensor Linking Metabolic and Inflammatory Diseases | Q38594132 | ||
| Aspergillus infections in cystic fibrosis | Q38833989 | ||
| Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions | Q38843831 | ||
| The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease | Q38853672 | ||
| A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs | Q38882885 | ||
| Volatile Compounds Emitted by Pseudomonas aeruginosa Stimulate Growth of the Fungal Pathogen Aspergillus fumigatus | Q39486474 | ||
| Th17/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines. | Q39488014 | ||
| Microbial Biofilms in Pulmonary and Critical Care Diseases. | Q40635408 | ||
| Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation | Q40787967 | ||
| Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management | Q40859210 | ||
| Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis | Q40974392 | ||
| Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity | Q41171975 | ||
| PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant | Q41228764 | ||
| The β-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22. | Q41812432 | ||
| P433 | issue | 6 | |
| P921 | main subject | microbiome | Q1330402 |
| P304 | page(s) | 673-684 | |
| P577 | publication date | 2016-11-07 | |
| P1433 | published in | Virulence | Q18712614 |
| P1476 | title | The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases | |
| P478 | volume | 8 |
Search more.